The Cutting Edge of Medical Technology Content, Community & Collaboration
Time: September 26, 2013 at 9am to September 27, 2013 at 6pm
Location: United States
City/Town: Minneapolis
Website or Map: http://bit.ly/14G2c2H
Phone: 8004479407
Event Type: conference
Organized By: John Robinson
Latest Activity: Aug 19, 2013
Overview:
Writing SOPs or procedural documents can be challenging at times. However, writing SOPs is overall a straightforward process. However, enforcing what you already created and implemented in the pipeline is another story. The term SOP is very obvious. We have seen "clearly written description of how specific tasks are to be done." Another satisfactory definition would be "detailed written instructions that achieve the uniformity of the performance of a specific function." Is the firm doing what the regulations specify? Is the firm doing what their procedures specify? If you are medical device or a pharmaceutical manufacturer, these definitions come as no surprise because when it comes to FDA regulations and guidance documents "establish" means to define, to document (in writing or electronically) and to implement. The goal and emphasis with FDA is simple. Proof of "Establish" is the foundation. Is the firm doing what the regulations specify? Is the firm doing what their procedures specify? Are the procedures being followed and enforced by company personnel? SOPs are needed in regulated industries to give step-by-step instructions for performing a particular job or task. This session will provide a step-by-step overview and a snapshot of the procedure description, the process and format. The subject matter of a SOP may range from how to operate a piece of machinery to how to log into a particular software program. SOPs ensure consistency and reliability because they require training of all affected parties.
This session will address recent enforcement actions for SOP related violations but no surprise. Most of our enforcement actions are documentation related, i.e., SOP or other procedural documents.
Who Will Benefit:
Speaker Profile:
David R. Dills, Regulatory Affairs & Compliance Consultant currently provides regulatory, compliance and quality consultative services for medical device and pharmaceutical/combination manufacturers, and also has an accomplished record with more than 24 years of experience with Class I/II/III medical devices, In Vitro diagnostics, and pharmaceuticals in the areas of Regulatory Affairs, Compliance and Quality Systems. He has been previously employed, with increasing responsibilities by medical device manufacturers and consultancies, including a globally recognized CRO.
DATE, VENUE & PRICE:
Location: Minneapolis, MN| Sep 26th & 27th, 2013 | 9 AM to 6 PM PDT
Venue: WILL BE ANNOUNCED SOON
Price: $1295.00
Contact Information:
Event Coordinator
Toll free: 1800 447 9407
Fax: 302 288 6884
Email: support@globalcompliancepanel.com
Website: https://www.globalcompliancepanel.com
LIVE CHAT SUPPORT ALSO - http://www.globalcompliancepanel.com/chat/client.php
GlobalCompliancePanel
NetZealous LLC
161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA
For More Details: http://bit.ly/14G2c2H
© 2025 Created by CC-Conrad Clyburn-MedForeSight. Powered by
RSVP for 2-day In-person Seminar on “Writing and Enforcing Effective SOPs” at Minneapolis to add comments!
Join MedTech I.Q.